Successful treatment of <em>Staphylococcus haemolyticus</em> endocarditis in extremely premature baby with daptomycin

Abstract

Daptomycin is a novel lipopeptide antibiotic with rapid activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. We are reporting the first case of successfully using daptomycin to treat infective endocarditis in an extremely premature baby.

Keywords

• endocarditis
• daptomycin
• neonate
• premature
• staphylococcus haemolyticus
• sepsis